Panhematin (RECORDATI RARE DISEASES, INC.)


Welcome to the PulseAid listing for the Panhematin drug offered from RECORDATI RARE DISEASES, INC.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: RECORDATI RARE DISEASES, INC.
NON-PROPRIETARY NAME: hemin
SUBSTANCE NAME: HEMIN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: INTRAVENOUS
DOSAGE FORM: POWDER, FOR SOLUTION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 1983-07-20
END MARKETING DATE: 0000-00-00


Panhematin HUMAN PRESCRIPTION DRUG Details:

Item DescriptionPanhematin from RECORDATI RARE DISEASES, INC.
LABELER NAME: RECORDATI RARE DISEASES, INC.
DEA SCHEDULE:
ACTIVE STRENGTH: 7(mg/mL)
START MARKETING DATE: 1983-07-20
END MARKETING DATE: 0000-00-00
PRODUCT ID: 55292-702_ba89eb18-9ccb-42b3-95cf-7493def009a3
PRODUCT NDC: 55292-702
APPLICATION NUMBER: BLA101246

Other HEMIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
RECORDATI RARE DISEASES, INC.Panhematin